Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 78.00
-0.70 (-0.89%)
Sep 30, 2026, 1:30 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 2.13 billion as of September 29, 2026. Its market cap has decreased by -36.28% in one year.
Market Cap
2.13B
Enterprise Value
2.09B
Revenue
2.05B
Ranking
n/a
PE Ratio
9.45
Stock Price
78.00
ChartMarket Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 2.13B, an increase of 473.34%. That is a compound annual growth rate of 8.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 2.13B | -32.16% |
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.63B |
| Chunghwa Chemical Synthesis & Biotech | 2.59B |
| 3D Global Biotech | 2.51B |
| GlycoNex Incorporation | 2.47B |
| HeXun Biosciences | 2.31B |
| Taiwan Bio Therapeutics | 2.22B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.11B |
| G&E Herbal Biotechnology | 1.99B |